Skip to content

Clinical trials

Completed Lung Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Poland Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20041
20053
20061
20072
20085
20091
20103
20111
20122
20132
20144
20155
20164
20171
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
European Organisation for Research and Treatment of Cancer - EORTC5
Amgen3
AstraZeneca2
Eli Lilly and Company2
Gustave Roussy, Cancer Campus, Grand Paris2
Novartis Pharmaceuticals2
Pfizer2
Sanofi2
Achieve Life Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms46
Carcinoma, Non-Small-Cell Lung23
Small Cell Lung Carcinoma5
Breast Neoplasms4
Neoplasm Metastasis4
Neoplasms4
Adenocarcinoma of Lung2
Carcinoma2
Colorectal Neoplasms2
Kidney Neoplasms2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.